Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • July 2011 | Volume 24 - Issue 7
    Tracey C. Vlahovic, DPM
    25,534 reads | 0 comments | 06/21/11
    Given the changing population demographics in the United States, it is more important than ever to be able to recognize and treat dermatologic conditions that are more prevalent among patients with skin of color. Accordingly, this author discusses the diagnosis and treatment of skin conditions including vitiligo, melanonychia and keloids. ... continue reading
    Alan Catanzariti, DPM, FACFAS, and Robert Mendicino, DPM, FACFAS
    12,064 reads | 0 comments | 06/21/11
    When conservative care fails for the Charcot foot, the ostectomy can be a viable surgical alternative. Accordingly, these authors offer a closer look at factors to consider before proceeding with an ostectomy, pertinent insights on the procedure and keys to minimizing the risk of post-op complications. ... continue reading
    Brian McCurdy, Senior Editor
    29,689 reads | 0 comments | 06/21/11
    Podiatric technology continues to advance and the profession has seen recent innovations in areas such as wound care, surgery and the diabetic foot. Experts in various aspects of podiatry provide insights on acellular dermal matrices, a hammertoe implant, a diabetic insole and other podiatric advances. ... continue reading
    Clinical Editor: Kazu Suzuki, DPM, CWS
    20,912 reads | 0 comments | 06/21/11
    Wound debridement is the foundation for successful and swift wound healing. Appropriate and timely wound debridement facilitates infection control by removing the biofilm over wound surfaces. Our expert panelists discuss best practices in wound debridement by reviewing the clinical evidence for wound debridement, patient education and insights on the vascular workup of patients with wounds. ... continue reading
    Shelby Swanson, BA, Andrea Dyack, BS, BA, and Michael S. Lee, DPM, FACFAS
    24,147 reads | 1 comments | 06/21/11
    Arthrodesis of the first metatarsophalangeal joint (MPJ) was first advocated in 1894 by Clutton for severe, painful hallux valgus.1 McKeever refined the technique in 1952 using intramedullary screw fixation, which is currently the gold standard for treatment of advanced arthritis and/or significant deformities of the hallux.2 Common indications for arthrodesis include stage 3 hallux rigidus (osteoarthritis), rheumatoid arthritis, failed first MPJ implants, severe hallux valgus deformities and post-traumatic arthritis.3,4 ... continue reading

    5,268 reads | 0 comments | 06/21/11
    Neurology examine the efficacy of different modalities for painful diabetic neuropathy."> New evidence-based guidelines for painful diabetic neuropathy, recently published in Neurology, examine the efficacy of various types of modalities to relieve the pain of diabetic neuropathy. The authors note that pregabalin (Lyrica, Pfizer) is effective for Level A neuropathy while venlafaxine (Effexor, Pfizer), duloxetine (Cymbalta, Eli Lilly), amitriptyline (Elavil, Merck), gabapentin (Neurontin, Pfizer), valproate (Depacon, Abbott Laboratories), opioids and capsaicin are effective for Level B neuropathy. ... continue reading